Parameters that show the systemic inflammatory response, such as increased CRP and reduced albumin levels, have been shown to be associated with prognosis in various cancers, particularly in patients with non-small-cell lung cancer, pancreatic adenocarcinoma, gastric cancer, colorectal cancers, and renal cell carcinoma [17]. Here, ALB is linked to non-small cell lung carcinoma.